These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 11389614

  • 21. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y, Machado F, Juliano L, Juliano MA, Brentani RR, Foguel D, Silva JL.
    J Biol Chem; 2001 Dec 28; 276(52):49400-9. PubMed ID: 11604397
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
    Cobb NJ, Sönnichsen FD, McHaourab H, Surewicz WK.
    Proc Natl Acad Sci U S A; 2007 Nov 27; 104(48):18946-51. PubMed ID: 18025469
    [Abstract] [Full Text] [Related]

  • 26. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
    De Gioia L, Selvaggini C, Ghibaudi E, Diomede L, Bugiani O, Forloni G, Tagliavini F, Salmona M.
    J Biol Chem; 1994 Mar 18; 269(11):7859-62. PubMed ID: 7907586
    [Abstract] [Full Text] [Related]

  • 27. Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.
    Dima RI, Thirumalai D.
    Biophys J; 2002 Sep 18; 83(3):1268-80. PubMed ID: 12202354
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
    Sang JC, Lee CY, Luh FY, Huang YW, Chiang YW, Chen RP.
    Prion; 2012 Sep 18; 6(5):489-97. PubMed ID: 22987112
    [Abstract] [Full Text] [Related]

  • 31. Assembly of the full-length recombinant mouse prion protein I. Formation of soluble oligomers.
    Vendrely C, Valadié H, Bednarova L, Cardin L, Pasdeloup M, Cappadoro J, Bednar J, Rinaudo M, Jamin M.
    Biochim Biophys Acta; 2005 Aug 05; 1724(3):355-66. PubMed ID: 15975719
    [Abstract] [Full Text] [Related]

  • 32. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
    Corsaro A, Anselmi C, Polano M, Aceto A, Florio T, De Nobili M.
    J Biol Regul Homeost Agents; 2010 Aug 05; 24(1):27-39. PubMed ID: 20385069
    [Abstract] [Full Text] [Related]

  • 33. Kinetic intermediate in the folding of human prion protein.
    Apetri AC, Surewicz WK.
    J Biol Chem; 2002 Nov 22; 277(47):44589-92. PubMed ID: 12356762
    [Abstract] [Full Text] [Related]

  • 34. Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations.
    Jackson GS, Hosszu LL, Power A, Hill AF, Kenney J, Saibil H, Craven CJ, Waltho JP, Clarke AR, Collinge J.
    Science; 1999 Mar 19; 283(5409):1935-7. PubMed ID: 10082469
    [Abstract] [Full Text] [Related]

  • 35. Charge neutralization of the central lysine cluster in prion protein (PrP) promotes PrP(Sc)-like folding of recombinant PrP amyloids.
    Groveman BR, Kraus A, Raymond LD, Dolan MA, Anson KJ, Dorward DW, Caughey B.
    J Biol Chem; 2015 Jan 09; 290(2):1119-28. PubMed ID: 25416779
    [Abstract] [Full Text] [Related]

  • 36. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
    Bertho G, Bouvier G, Hoa GH, Girault JP.
    Peptides; 2008 Jul 09; 29(7):1073-84. PubMed ID: 18455265
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Binding of prion proteins to lipid membranes.
    Critchley P, Kazlauskaite J, Eason R, Pinheiro TJ.
    Biochem Biophys Res Commun; 2004 Jan 16; 313(3):559-67. PubMed ID: 14697227
    [Abstract] [Full Text] [Related]

  • 40. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T, Zahn R, Wüthrich K.
    J Mol Biol; 2006 Mar 31; 357(3):833-41. PubMed ID: 16466741
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.